How will the contract size and timeline affect L3Harris's near‑term revenue and earnings forecasts? | LHX (Aug 28, 2025) | Candlesense

How will the contract size and timeline affect L3Harris's near‑term revenue and earnings forecasts?

Fundamental impact

Because the Polish purchase is part of a government‑to‑government transaction that must be routed through the U.S. State Department, L3Harris will only book the contract value as billings when the deal is officially awarded—likely in the next 1‑2 months. The Viper‑Shield system is a “off‑the‑shelf” electronic‑warfare package, so billings will be modest relative to the company’s multi‑billion‑dollar defense pipeline (historically 5‑7 % of annual revenue for a single F‑16‑type EW upgrade). Revenue will therefore be recognized incrementally as hardware and software are delivered, which spreads the top‑line lift over the next 12‑18 months rather than delivering a single‑quarter spike. The near‑term effect on earnings is even softer: most of the profit‑margin upside will accrue later, when the high‑margin software sustain‑ment and spares contracts kick in.

Trading implications

The market should price the contract as a near‑term catalyst that nudges L3Harris’s Q3‑Q4 guidance upward—perhaps a 1‑2 % revenue bump and a 3‑4 % earnings‑before‑interest‑tax‑depreciation‑amortisation (EBITDA) lift once the initial deliveries are booked. In practice, this translates to a modest upside in the stock, especially if management flags the deal as the first of a broader Eastern‑Europe F‑16 upgrade program, which could seed farther‑down‑track growth. From a technical standpoint, L3Harris has been holding above its 50‑day 20‑day MA, and a break toward the 200‑day MA at ~ $330 could signal the market is still undervaluing the incremental upside. A buy‑on‑dip if the price falls 3‑5 % below the 20‑day MA, with a target of $355‑$370 (≈ 5‑7 % upside) once the company releases an updated FY‑2025 outlook. Conversely, watch for any guidance dampening related to supply‑chain delays; such a scenario could cap the upside and trigger a pull‑back toward $310‑$320.